New device enables improved retinal imaging in periphery

Article

The P200C, a retinal imaging device designed for advanced ocular disease, has been launched by Optos plc.

The P200C, a retinal imaging device designed for advanced ocular disease, has been launched by Optos plc. This device is complementary to the firm's Panoramic200 Scanning Laser Ophthalmoscope (P200), which is used for the early detection of retinal conditions such as glaucoma, diabetic retinopathy and age-related macular degeneration, and for non-eye diseases including diabetes and hypertension.

The P200C is intended to be used in the advanced clinical optometry and ophthalmology markets. Its design improves image accuracy, allowing the capture of images in the mid to very far periphery of the retina by potentially reaching the ora serrata and increasing productivity with its ergonomic patient interface.

Optos plans to market the P200C primarily on a pay-per-patient basis to an estimated 10,000 addressable practice locations in its existing markets of the UK, Germany, the US and Canada.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.